在COVID-19中以C1酶抑制剂为媒介的免疫抑制:朋友还是敌人?

Melissa A Hausburg1,2,3, Jason S Williams1,2,3, Kaysie L Banton1

  • 1Department of Trauma Research, Swedish Medical Center, 501 E. Hampden, Englewood, CO 80113, USA.

PubMed
概括

严重的COVID-19涉及异常补体和XIIa因子的激活. C1雌激酶抑制剂 (C1-INH) 矛盾地增加,可能被SARS-CoV-2抑制,影响免疫反应.